查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1565674

暴露前预防 (PrEP) 市场，按产品类型、按使用类型、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Pre-Exposure Prophylaxis (PrEP) Market, By Product Type, By Usage Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年暴露前预防（PrEP）市场规模为49.8043亿美元，2024年至2032年复合年增长率为12.30%。

暴露前预防 (PrEP) 市场-市场动态

提高对 PrEP 有效性和可用性的认识和教育。

对 PrEP 有效性和可用性的认识和教育的提高极大地推动了 PrEP 市场的发展。随着越来越多的人了解 PrEP 如何预防爱滋病毒，对该药物的需求不断增加。美国疾病管制与预防中心 (CDC) 报告称，宣传活动的加强导致高风险族群中 PrEP 的使用大幅增加。

美国疾病管制与预防中心 (CDC) 报告称，截至 2021 年，近 60% 的 HIV 高风险族群了解 PrEP。 CDC 也指出，从 2018 年到 2021 年，PrEP 处方数量增加了 25%，反映出人们对这种预防性治疗的认识和采用不断增强。认知度和利用率的提高是 PrEP 市场不断扩大的关键驱动力。

暴露前预防 (PrEP) 市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 12.30% 左右的复合年增长率成长

根据产品类型细分，预计品牌 PrEP 将在 2023 年显示最大的市场份额

根据使用类型细分，每日口服 PrEP 是 2023 年的主导类型

按地区划分，北美是 2023 年的主要收入来源

暴露前预防 (PrEP) 市场区隔分析：

全球暴露前预防 (PrEP) 市场根据产品类型、使用类型、最终用户和地区进行细分。

依产品类型，市场分为两类：通用 PrEP、品牌 PrEP。在暴露前预防 (PrEP) 市场中，品牌 PrEP 细分市场目前占据主导地位。这主要归功于 Truvada 和 Descovy 等品牌产品的强大市场影响力和广泛推广。品牌 PrEP 受益于既定的品牌知名度、全面的临床支援和广泛的分销网络。由于其经过验证的功效和安全性，它们也经常获得医疗保健提供者的优先推荐。相较之下，通用 PrEP 虽然可用性有所增加，但由于品牌认知度较低且可能不太全面的支持，在获得市场份额方面仍面临挑战。

根据每日口服 PrEP 的使用类型，市场分为两类。长效注射剂 在暴露前预防 (PrEP) 市场中，每日口服 PrEP 市场目前占据主导地位。这种主导地位源于每日口服 PrEP 的长期使用和临床验证，例如 Truvada 和 Descovy，它们在功效和安全性方面拥有良好的记录。每日口服 PrEP 已被医疗保健提供者广泛使用和接受，为其带来了巨大的市场份额。长效注射剂正在兴起，但由于市场进入较新且长期资料点较少，尚未达到相同水平的市场渗透率。

暴露前预防 (PrEP) 市场 - 地理洞察

暴露前预防 (PrEP) 市场最大的地区是北美，尤其是美国。该地区领先的原因在于其先进的医疗基础设施、对爱滋病毒预防的高度认识以及公共卫生倡议的大力支持。美国也受惠于 PrEP 药物研发的大量投资。透过各种医疗保健计划和保险范围提供 PrEP 进一步促进了其采用。北美市场的主导地位得到了强有力的监管框架和积极推广 PrEP 使用的倡议团体的支持。

暴露前预防 (PrEP) 市场-竞争格局：

暴露前预防 (PrEP) 市场竞争激烈，几个主要参与者占据主导地位。吉利德科学公司 (Gilead Sciences, Inc.) 凭藉其 PrEP 产品 Truvada 及其新配方 Descovy 处于领先地位。 ViiV Healthcare 紧随其后推出了 Apretude，这是一种长效注射 PrEP 选项。百时美施贵宝和杨森製药公司也很重要，它们正在进行研究和潜在的 PrEP 开发。默克公司和艾伯维公司透过其 HIV 研究和新兴的 PrEP 解决方案做出贡献。罗氏和辉瑞公司参与爱滋病毒治疗，影响 PrEP 市场。 Sage Therapeutics 和 Moderna, Inc. 是探索新预防方法的创新企业。 Mylan NV、Hikma Pharmaceuticals、Cipla Limited 和 Aurobindo Pharma 提供通用 PrEP 选项，扩大了可近性和可负担性。这种竞争格局的特点是不断创新和发展，旨在改善爱滋病毒的预防和治疗结果。

最新进展：

2024 年 9 月，随着第三阶段的另一场胜利，吉利德正竞相在 2025 年推出长效 PrEP 药物。

2023年4月，默克公司（MRK.N）表示将以约108亿美元收购Prometheus Biosciences Inc.（RXDX.O）。此次收购将使默克扩大在免疫学领域的立足点，并获得治疗溃疡性结肠炎和克隆氏症的潜在实验性治疗方法。

目录

第 1 章：暴露前预防 (PrEP) 市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的暴露前预防 (PrEP) 市场片段
    • 按使用类型分類的暴露前预防 (PrEP) 市场片段
    • 最终使用者的暴露前预防 (PrEP) 市场片段
    • 按国家/地区分類的暴露前预防 (PrEP) 市场片段
    • 按地区分類的暴露前预防 (PrEP) 市场片段
  • 竞争洞察

第 3 章：暴露前预防 (PrEP) 主要市场趋势

  • 暴露前预防 (PrEP) 市场驱动因素
    • 市场驱动因素的影响分析
  • 暴露前预防 (PrEP) 市场限制
    • 市场限制影响分析
  • 暴露前预防 (PrEP) 市场机会
  • 暴露前预防 (PrEP) 市场未来趋势

第 4 章：暴露前预防 (PrEP) 产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：暴露前预防 (PrEP) 市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：暴露前预防 (PrEP) 市场格局

  • 2023 年暴露前预防 (PrEP) 市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：暴露前预防 (PrEP) 市场 - 依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 通用 PrEP
    • 品牌 PrEP

第 8 章：暴露前预防 (PrEP) 市场 - 依使用类型

  • 概述
    • 按使用类型分類的细分市场份额分析
    • 每日口服 PrEP
    • 长效注射剂

第 9 章：暴露前预防 (PrEP) 市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院和诊所
    • 社区健康服务中心
    • 专门的爱滋病毒诊所

第 10 章：暴露前预防 (PrEP) 市场 - 依地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美暴露前预防 (PrEP) 主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按使用类型）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲暴露前预防 (PrEP) 主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按使用类型）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区暴露前预防 (PrEP) 主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模和预测（按使用类型）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲暴露前预防 (PrEP) 主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按使用类型）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲暴露前预防 (PrEP) 主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模和预测（按使用类型）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 暴露前预防 (PrEP) 产业

  • 竞争仪表板
  • 公司简介
    • Gilead Sciences, Inc.
    • ViiV Healthcare
    • Bristol-Myers Squibb
    • Janssen Pharmaceuticals
    • Merck & Co., Inc.
    • AbbVie Inc.
    • Roche
    • Pfizer Inc.
    • Sage Therapeutics
    • Moderna, Inc.
    • Mylan NV
    • Hikma Pharmaceuticals
    • Cipla Limited
    • Aurobindo Pharma

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3845

REPORT HIGHLIGHT

Pre-Exposure Prophylaxis (PrEP) Market size was valued at USD 4,980.43 Million in 2023, expanding at a CAGR of 12.30% from 2024 to 2032.

Pre-exposure prophylaxis (PrEP) is a preventive treatment for high-risk individuals to reduce HIV infection. It involves taking a daily pill containing antiretroviral drugs. The PrEP market includes developing, manufacturing, and distributing these medications. This market has expanded due to increased HIV prevention awareness and access. Key players include pharmaceutical companies and healthcare providers. Ongoing research aims to improve PrEP options and explore new formulations.

Pre-Exposure Prophylaxis (PrEP) Market- Market Dynamics

Increased awareness and education about PrEP's effectiveness and availability.

Increased awareness and education about PrEP's effectiveness and availability significantly drive the PrEP market. As more people understand how PrEP can prevent HIV, demand for the drug rises. the Centers for Disease Control and Prevention (CDC) reported that increased awareness campaigns led to a substantial rise in PrEP use among high-risk populations.

The U.S. Centers for Disease Control and Prevention (CDC) reported that as of 2021, nearly 60% of individuals at high risk of HIV were aware of PrEP. The CDC also noted a 25% increase in PrEP prescriptions from 2018 to 2021, reflecting this preventive treatment's growing awareness and adoption. This rise in awareness and utilization is a key driver for the expanding PrEP market.

Pre-Exposure Prophylaxis (PrEP) Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.30% over the forecast period (2024-2032)

Based on product type segmentation, branded PrEP was predicted to show maximum market share in the year 2023

Based on Usage Type segmentation, daily oral PrEP was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Pre-Exposure Prophylaxis (PrEP) Market- Segmentation Analysis:

The Global Pre-Exposure Prophylaxis (PrEP) Market is segmented on the basis of Product Type, Usage Type, End User, and Region.

The market is divided into two categories based on product type Generic PrEP, Branded PrEP. In the Pre-Exposure Prophylaxis (PrEP) market, the branded PrEP segment is currently the most dominant. This is largely due to the strong market presence and extensive promotion of branded products like Truvada and Descovy. Branded PrEPs benefit from established brand recognition, comprehensive clinical support, and extensive distribution networks. They also often receive preferential recommendations from healthcare providers due to their proven efficacy and safety profiles. In contrast, generic PrEPs, while increasing in availability, still face challenges in gaining market share due to lower brand recognition and potentially less comprehensive support.

The market is divided into two categories based on the Usage Type Daily Oral PrEP. Long-Acting Injectables In the Pre-Exposure Prophylaxis (PrEP) market, the daily oral PrEP segment is currently the most dominant. This dominance stems from the long-standing use and clinical validation of daily oral PrEP, such as Truvada and Descovy, which have a well-established track record for efficacy and safety. Daily oral PrEP is widely available and accepted by healthcare providers, contributing to its significant market share. Long-acting injectables are emerging but have not yet achieved the same level of market penetration due to newer market entry and fewer long-term data points.

Pre-Exposure Prophylaxis (PrEP) Market- Geographical Insights

The largest region for the Pre-Exposure Prophylaxis (PrEP) market is North America, particularly the United States. This region leads due to its advanced healthcare infrastructure, high awareness of HIV prevention, and strong support from public health initiatives. The U.S. also benefits from significant investments in research and development for PrEP medications. The availability of PrEP through various healthcare programs and insurance coverage further boosts its adoption. North America's market dominance is supported by robust regulatory frameworks and active advocacy groups promoting PrEP usage.

Pre-Exposure Prophylaxis (PrEP) Market- Competitive Landscape:

The Pre-Exposure Prophylaxis (PrEP) market is highly competitive, with several major players dominating the landscape. Gilead Sciences, Inc.leads with its PrEP product, Truvada, and its newer formulation, Descovy. ViiV Healthcare follows with Apretude, a long-acting injectable PrEP option. Bristol-Myers Squibb and Janssen Pharmaceuticals are also significant, with ongoing research and potential PrEP developments. Merck & Co., Inc. and AbbVie Inc. contribute through their HIV research and emerging PrEP solutions. Roche and Pfizer Inc. are involved in HIV treatments, influencing the PrEP market. Sage Therapeutics and Moderna, Inc. are innovative players exploring new prevention methods. Mylan N.V., Hikma Pharmaceuticals, Cipla Limited, and Aurobindo Pharma provide generic PrEP options, expanding access and affordability. This competitive landscape is characterized by continuous innovation and development aimed at improving prevention and treatment outcomes for HIV.

Recent Developments:

In September 2024, with yet another phase 3 victory, Gilead is racing to introduce a long-acting PrEP medication in 2025.

In April 2023, Merck & Co. (MRK.N) said that it will acquire Prometheus Biosciences Inc. (RXDX.O) for approximately $10.8 billion. The acquisition will allow Merck to expand its foothold in immunology and acquire a potential experimental treatment for ulcerative colitis and Crohn's disease.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PRE-EXPOSURE PROPHYLAXIS (PREP) MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Gilead Sciences, Inc.
  • ViiV Healthcare
  • Bristol-Myers Squibb
  • Janssen Pharmaceuticals
  • Merck & Co., Inc.
  • AbbVie Inc.
  • Roche
  • Pfizer Inc.
  • Sage Therapeutics
  • Moderna, Inc.
  • Mylan N.V.
  • Hikma Pharmaceuticals
  • Cipla Limited
  • Aurobindo Pharma

GLOBAL PRE-EXPOSURE PROPHYLAXIS (PREP) MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Generic PrEP
  • Branded PrEP

GLOBAL PRE-EXPOSURE PROPHYLAXIS (PREP) MARKET, BY USAGE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Daily Oral PrEP
  • Long-Acting Injectables

GLOBAL PRE-EXPOSURE PROPHYLAXIS (PREP) MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Community Health Centers
  • Specialized HIV Clinics

GLOBAL PRE-EXPOSURE PROPHYLAXIS (PREP) MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pre-Exposure Prophylaxis (PrEP) Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pre-Exposure Prophylaxis (PrEP) Market Snippet by Product Type
    • 2.1.2. Pre-Exposure Prophylaxis (PrEP) Market Snippet by Usage Type
    • 2.1.3. Pre-Exposure Prophylaxis (PrEP) Market Snippet by End User
    • 2.1.4. Pre-Exposure Prophylaxis (PrEP) Market Snippet by Country
    • 2.1.5. Pre-Exposure Prophylaxis (PrEP) Market Snippet by Region
  • 2.2. Competitive Insights

3. Pre-Exposure Prophylaxis (PrEP) Key Market Trends

  • 3.1. Pre-Exposure Prophylaxis (PrEP) Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pre-Exposure Prophylaxis (PrEP) Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pre-Exposure Prophylaxis (PrEP) Market Opportunities
  • 3.4. Pre-Exposure Prophylaxis (PrEP) Market Future Trends

4. Pre-Exposure Prophylaxis (PrEP) Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pre-Exposure Prophylaxis (PrEP) Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Pre-Exposure Prophylaxis (PrEP) Market Landscape

  • 6.1. Pre-Exposure Prophylaxis (PrEP) Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pre-Exposure Prophylaxis (PrEP) Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Generic PrEP
    • 7.1.3. Branded PrEP

8. Pre-Exposure Prophylaxis (PrEP) Market - By Usage Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Usage Type, 2023 & 2032 (%)
    • 8.1.2. Daily Oral PrEP
    • 8.1.3. Long-Acting Injectables

9. Pre-Exposure Prophylaxis (PrEP) Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospitals and Clinics
    • 9.1.3. Community Health Centers
    • 9.1.4. Specialized HIV Clinics

10. Pre-Exposure Prophylaxis (PrEP) Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Pre-Exposure Prophylaxis (PrEP) Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Pre-Exposure Prophylaxis (PrEP) Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Pre-Exposure Prophylaxis (PrEP) Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Pre-Exposure Prophylaxis (PrEP) Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Pre-Exposure Prophylaxis (PrEP) Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Pre-Exposure Prophylaxis (PrEP) Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Gilead Sciences, Inc.
    • 11.2.2. ViiV Healthcare
    • 11.2.3. Bristol-Myers Squibb
    • 11.2.4. Janssen Pharmaceuticals
    • 11.2.5. Merck & Co., Inc.
    • 11.2.6. AbbVie Inc.
    • 11.2.7. Roche
    • 11.2.8. Pfizer Inc.
    • 11.2.9. Sage Therapeutics
    • 11.2.10. Moderna, Inc.
    • 11.2.11. Mylan N.V.
    • 11.2.12. Hikma Pharmaceuticals
    • 11.2.13. Cipla Limited
    • 11.2.14. Aurobindo Pharma

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us